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Abstract
Background
Lactic acid bacteria (LAB) have been considered as potentially probiotic organisms due to
their potential human health properties. This study aimed to evaluate both in vitro and in
vivo, the potential probiotic properties of Lactobacillus species isolated from fecal samples
of healthy humans in Iran.
Methods and Results
A total of 470 LAB were initially isolated from 53 healthy individual and characterized to spe-
cies level. Of these, 88 (86%) were Lactobacillus species. Biochemical and genetic finger-
printing with Phene-Plate system (PhP-LB) and RAPD-PCR showed that the isolates were
highly diverse consisted of 67(76.1%) and 75 (85.2%) single types (STs) and a diversity
indices of 0.994 and 0.997, respectively. These strains were tested for production of adhe-
sion to Caco-2 cells, antibacterial activity, production of B12, anti-proliferative effect and
interleukin-8 induction on gut epithelial cell lines and antibiotic resistance against 9 com-
monly used antibiotics. Strains showing the characteristics consistent with probiotic strains,
were further tested for their anti-inflammatory effect in mouse colitis model. Only one L. bre-
vis; one L. rhamnosus and two L. plantarumwere shown to have significant probiotic proper-
ties. These strains showed shortening the length of colon compared to dextran sulfate
sodium and disease activity index (DAI) was also significantly reduced in mouse.
Conclusion
Low number of LAB with potential probiotic activity as well as high diversity of lactobacilli
species was evident in Iranian population. It also suggest that specific strains of L. plan-
tarum, L. brevis and L. rhamnosus with anti-inflammatory effect in mouse model of colitis
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could be used as a potential probiotic candidate in inflammatory bowel disease to decrease
the disease activity index.
Introduction
The concept of using live bacterial species such as Lactobacillus spp. with health benefit has
received a great deal of attention in recent years. It is well known that the gastrointestinal (GI)
tract is the home to a vast number of bacterial species, with vital roles in maintaining GI func-
tionality including up to 70% of the immune system activity [1]. The probiotics are recom-
mended as a preventive approach to maintain the balance of intestinal microbiota [2].
Amongst various microbiota, Lactobacillus sp. is especially important for the maintenance of
the human intestinal microbial ecosystem [3] which, in turn, may affect the quality of life. It
has been indicated that the disturbances in the normal microbiota of the GI tract may lead to
dysbiosis and ultimately clinical disease expression [4].
Probiotics have been used to modulate immunity, reduction of cholesterol, symptoms of
crohn’s disease, atopic dermatitis, diarrhea and constipation duration and also to treat disease
conditions such as candidiasis, urinary tract infections and rheumatoid arthritis [5].
In recent years, various studies have shown that resident bacterial flora play a central role in
pathogenesis of inflammatory bowel diseases (IBD) [6], partly, due to immunomodulatory
properties of probiotic organisms [7] indicating a their role in prevention and/or therapy of
IBD cases [8, 9]
Isolation of probiotic bacteria and determination of their biological activities has been
under intensive investigations in developed countries. However, less attention has been given
in developing or under-developed countries where the idea of the probiotic is still in its infancy.
In this study we aimed to isolate and characterize Lactobacillus species with probiotic proper-
ties from fecal samples of healthy populations in Iran with special focus on their efficacy in an
animal model of IBD.
Materials and Methods
Experimental Design
Fecal samples from 53 volunteers healthy individuals aged between 1 and 36 years old were col-
lected. The volunteers were of different background living in Tehran City, Iran (n = 32) and or
north part of Iran (n = 21). Criteria for selection of volunteers included lack of any antibiotic
therapy over 6 months pre-sampling, did not have any significant GI disorders or consumed
any probiotic products.
Fecal samples were serially dilutions in PBS (pH = 7.4)), plated onto Man, Rogosa and
Sharpe (MRS) agar (Merck, Germany) and incubated at 37°C for 48h in an anaerobic condi-
tion. From each sample 10 isolated colonies (where possible) was selected, further tested for
purification and kept at -80°C in MRS broth with 20% glycerol until tested.
pH and bile tolerance test
All LAB strains were initially tested for their ability to resist to bile salts and pH as described
before [10]. In brief, bacterial cells were grown overnight in MRS broth after which the culture
was centrifuged at 6000rpm and the pellets were washed in PBS. An initial count (C0) of the
bacterial suspension was performed after serial dilution (10−2 to 10−10)and plating on MRS
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agar followed by incubating plates anaerobically at 37°C for 48h. Then bacterial pellets re-sus-
pended in 5ml PBS and the pH was adjusted to 3.0 using HCl (Merck, Germany) and incubated
at 37°C for 3h. To determine the bile resistance property of the isolates, bacterial pellets, pre-
pared as described above, were re-suspended in MRS broth containing 0.4% bile salts (Merck,
Germany) and incubated for 6h. Harvested cells from the PBS at pH 3.0 were washed in PBS
and the enumeration of bacteria cells was performed as described above. Viable cells were
grouped as strongly resistant, resistant, intermediate and susceptible based on 2, 2–4, 4–6 and
>6 log reduction in comparison with the initial suspension after 3 and 6h of incubation in acid
and bile respectively.
Genus and species identification of Lactobacillus sp.
Total DNA was extracted using peqGOLD Bacterial DNA Kit (peQlab, Germany) according
to the manufacturer's instruction. Molecular identification of Lactobacillus genus was carried
out by PCR using the previously designed Lactobacillus 16s rRNA specific primers for-lac
(5´-TGGAAACAGGTGCTAATACCG-3´) and Rev-lac (5´-CCATTGTGGAAGATTCCC-3´)
[11]. The PCR was performed under the following conditions: 94°C for 5 minutes; 30 cycles of
94°C for 30 seconds, 57°C for 30 seconds and 72°C for 30 seconds, and a final extension step at
72°C for 7 minutes for all 102 acid and bile resistant LAB isolates.
For species identification of isolated Lactobacillus sp., multiplex PCR containing species-
specific primers for L. acidophilus, L. casei-group, L. delbrueckii, L. gasseri, L. plantarum, L.
rhamnosus and L. reuteri were used using the following conditions: after one cycle at 94°C for
5 min, 40 cycles of 94°C for 30 seconds, 51°C for 40 seconds and 72°C for 30 seconds were per-
formed. Final extension was carried out at 72°C for 7 minutes [12].
Phenotypic classification with Phene Plate system (PhPlate)
All acid and bile resistance lactobacilli isolates (n = 88) were subjected to a biochemical finger-
printing with the PhPlate system according to the manufacturer’s instructions (PhPlate Micro-
plate Techniques AB, Sweden) modified for lactobacilli (PhP-LB)typing. The microplates
(PhP-LB) contain 4 sets of dehydrated reagents (23 different sugar including arabinose, xylose,
galactose, maltose, cellobiose, trehalose, palatinose, sucrose, lactose, melibiose, mannose, mele-
zitose, inosin, mannitol, arbutin, sorbitol, gallactose, sorbose, rhamnose, taghatose, amygdalin,
gluconate, salicin) which have been specifically selected for typing of Lactobacilli. PhP-LB
plates were incubated at 37°C and bacterial utilization of the substrates of each well was mea-
sured after 24, 48, and 72h by scanning the images. Scanned images were analyzed by software
package PhPWIN (PhPlate Micro-plate Techniques AB, Sweden). Mean similarity between
duplicate assays of all strains -2 SD was calculated as identification level (ID) which was 0.975.
Strains with similarity more than 0.975 were regarded as identical and grouped to the same
PhP type.
Genotypic classification with RAPD-PCR
All 88 acid and bile resistance lactobacilli isolates were also subjected to Random Amplified
Polymorphic DNA (RAPD) using previously designed oligonucleotide OPL-05 and PL-1 with
some modifications [13]. PCR reaction for each primer was done in a separate tube and run in
the same well in 1.5% agarose gel for more discrimination. The PCR was performed with the
following conditions: 94°C for 2 minutes; 40 cycles of 94°C for 30 seconds, 37°C for 30 seconds
and 72°C for 2 minutes with a final extension step at 72°C for 10 minutes. Strains were clus-
tered with the UPGMAmethod using the software Gel compare II version 4.0 (Applied Maths,
Sint-Martens-Latem, Belgium).
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B12 production assay
All 88 isolated lactobacilli were tested for production of B12 vitamin based on competitive
binding radio assay using commercial kit Simultrac-SNB (MP Biomedicals, USA). Briefly, all
acid and bile resistance Lactobacillus strains were inoculated in MRS broth and incubated
anaerobically in 37°C for 96h. Supernatants were then collected after centrifugation and stored
at −80°C before assayed. The pellet radioactivity of each sample was counted using a gamma
counter (Laboratory Technologies Inc., USA). MRS broth medium without bacteria was used
as negative control.
Antibiotic susceptibility testing
The agar disc diffusion method was used to determine the antibiotic susceptibility patterns of
all acid and bile resistant lactobacilli isolates on MRS agar plate. Nine antibiotics including pen-
icillin G (10μg), gentamicin (120μg), erythromycin (15μg), tetracycline (30μg), amoxicillin
(25μg), ciprofloxacin (5μg), chloramphenicol (30μg), oxacillin (1μg), and streptomycin (10μg)
(MAST Diagnostics, U.K) were tested. The discs were placed on the agar plates, and incubated
at 37°C for 48h. The diameters of inhibition zones were measured and the results were
expressed as sensitive and resistant according to clinical and laboratory standards institute
(CLSI) guideline [14]. Because of the importance of resistance transfer in gut, resistant strains
to gentamicin, erythromycin, tetracycline and chloramphenicol were excluded from other
selections. Minimum inhibitory concentration (MIC) of ampicillin, vancomycin, gentamicin,
kanamycin, streptomycin, erythromycin, clindamycin and tetracycline was also conducted
according to Klare et al. [15].
Attachment to Caco-2 cells
The adherence of acid and bile resistance lactobacilli to Caco-2 cells was examined as previ-
ously described by Jacobsen et al. [3]. Caco-2 cells were cultured in a monolayer with RPMI
(Gibco, Carlsbad, CA, USA) with 20% (v/v) fetal calf serum (Gibco, Life Technology, USA)
and antibiotics (100U. ml-1 penicillin, 100mg.ml-1 streptomycin) at 37°C in a 5% CO2 atmo-
sphere. Initially, 3ml of Caco-2 cells with 1.5×105cells/ml were seeded on 6-well cell culture
plates and after confluency the cells were washed twice with 3ml PBS. An aliquot of two ml of
RPMI (without antibiotics) was added to each well and incubated at37°C for 3h. Bacterial cul-
tures (109cfu/ml) were suspended in 1ml RPMI1640 medium (without antibiotics) and then
added to different wells. The plates were incubated at 37°C in 5% CO2 for 1h. After incubation,
all of the wells were washed four times with PBS to release unbound bacteria and filled with 1
ml methanol and incubated for 5–10min at room temperature to fix cells and attached bacteria.
Staining was made with 3 ml of Giemsa stain solution (1:20) (Sigma-Aldrich Co., Mo, USA)
and incubated 30min at room temperature. Excess stain was removed with distilled water,
dried and examined under oil immersion microscope. The adherent lactobacilli in 20 random
microscopic fields were counted for each test and cells showing between 0 to 40 attached bacte-
ria in 20 fields were regarded as non-adhesive, while 41 to 100 attached bacteria were regarded
as an adhesive and>101 attached bacteria were regarded as strongly adhesive.
Determination of antibacterial activity
Based on data obtained from other screening tests (bile and acid resistance, attachment to
Caco-2 cells, antibiotic resistance pattern and B12 production), 20 Lactobacillus spp. were
selected and tested for their antimicrobial activity using an agar diffusion method as described
by Fernandez et al [16]. Suspensions of approximately 108cells/ml of pathogens including
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Shigella soneii (ATCC 12022), Pesudomonas aeruginosa (ATCC 27853), wild types of E. coli
strains belonging to three pathotypes i.e. enteropathogenic E. coli (EPEC) (ATCC 43887),
enterotoxigenic E. coli (ETEC) and enteroaggregative E. coli (EAEC) (ETEC and EAEC were
from our culture collection center at the Pasteur Institute of Iran and were not type strains)
[17, 18], Salmonella typhi (ATCC 19430), Proteus mirabilis (ATCC 25933), Yersinia enterocoli-
tica (ATCC 23715), Streptococcus agalactiea (ATCC 12386) and Listeria monocytogenes
(ATCC 19113) were poured on plates containing Muller Hinton agar, except for L.monocyto-
genes that was onto BHI agar. Plates were then punched with 6 mm diameter bores and each
well was filled with 100μl of the culture of selected Lactobacillus strains grown in MRS broth
overnight. The plates were then incubated at 37°C under aerobic condition for assessing the
antimicrobial effect of each Lactobacillus isolates. After 24h of incubation, one millimeter or
greater of inhibition zone were scored as positive antibacterial activity.
Anti-proliferation effect of LAB on Caco-2 cells
This was monitored using XTT [2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazo-
lium-5-Carboxanilide] assay for the 20 selected strains as previously described [19]. Caco-2
cells were seeded at a concentration of 2×105 cells/mL in 96-well plates with 250μl of fresh
RPMI1640 medium supplemented with glutamine 1% (w/v) and fetal calf serum [10% (v/v)] in
each well. Wells were then inoculated with Lactobacillus sp. isolates, at a multiplicity of infection
(MOI) of 100 alone. Microplates were incubated at 37°C under 5% CO2. After 16h, cell viability
was checked by trypan blue, supernatants were removed and cell monolayers were washed
twice in PBS. Then wells we refilled with 100μl of RMPI medium without phenol red and anti-
biotic and 50μl of XTT kit reagents (Roche, Germany) was added to each well and plates were
incubated at 37°C in 5% CO2. After 6h, formazan absorbance was assayed at 450nm. The per-
centage of proliferation was calculated as follows: OD positive−OD negative / OD negative × 100
where optical density positive (ODpositive) and negative (ODnegative) represent Caco-2 cells
treated with potentially probiotics and Caco-2 cells alone, respectively. The test was done in
triplicates.
Interleukin-8 induction
For determination of putative influence of 10 final selected strains in IL-8 production [19],
HT-29 cells were seeded at a concentration of 2×105 cells/ml in 24-well plates and cultured for
7 days at 37°C and 5% CO2 to reach confluence. The cell monolayer’s were washed twice with
PBS and then 250μl of fresh RPMI1640 medium supplemented with glutamine 1% (w/v) and
fetal calf serum [10% (v/v)]without antibiotics were added to each well. Monolayers were
treated by LPS (Sigma, Saint Louis, USA) at 100ng/ml and then bacterial culture were sus-
pended in 1 ml RPMI 1640 medium (without antibiotics) and then added to different wells at a
MOI of 100. For evaluation of absence of our selected Lactobacillus sp. non-activated HT-29
cells were treated with our selected bacteria. After 6h of incubation at 37°C and 5% CO2, cell
viability was checked and supernatants were stored at −80°C before being assayed. Quantifica-
tion of secreted IL-8 in all supernatants was done by ELISA test (eBioscience, Inc., San Diego,
USA) according to manufacture instruction.
The percentage of secreted IL-8 variation was calculated as follows:
Value assay  Value negative control= Value positive controlValue negative control  100
Where positive and negative controls represent HT-29 cells treated by LPS and HT-29 cells
alone without treatment, respectively. The test was done in triplicates.
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Anti-inflammatory effect of selected strains in mouse colitis model
The anti-inflammatory effect of the selected Lactobacillus strains was assessed in a chemically
induced inflammatory bowel disease (IBD) with dextran sulfate sodium (DSS) in Balb/c mice
as described before [20]. Balb/c mice (n = 60) were placed in groups of 5. Ten groups were
gavage with 0.5 ml PBS containing Lactobacillus spp. at the concentration of 109three days
before IBD induction and continued up to 7 days. After three days, water was replaced with
DSS solution in all cages except for the control group. All other groups that consumed DSS
solution were gavage with Lactobacillus spp. until day seven except for DSS control group.
Groups 3 to 12 were gavage with selected Lactobacillus spp. which included strains of L. plan-
tarum 42, L. plantarum 156, L. brevis 165, L. rhamnosus 195, L. brevis205, L. plantarum 240, L.
plantarum 241, L. plantarum 365, L. plantarum 467 and L. brevis 470. After day 10, all mice
were scarified and middle sections of colons were kept in 1.5 ml micro tube at -70°C until eval-
uation of myeloperoxidase (MPO) activity [20]. In this study three different features in the gut
of mice were compared between DSS group and other 11 groups for selection of most effective
isolates in preventing IBD induction in in vivomodel. These three features included colon
length, disease activity index (weight loss, stool consistency and occult/gross bleeding) and
MPO activity in the middle section of colon tissue [20, 21].
Statistical analysis
Statistical analysis was carried out using SPSS (version 16, SPSS Inc., Chicago, IL) software
package. The correlation between isolated species and age, birth place and gender of the volun-
teers with all biological activities were tested using non-parametric one-way ANOVA (Krus-
kal-wallis) and followed by Fisher’s least significant difference (LSD) for post hoc tests.
Differences of P< 0.05 were considered statistically significant.
Results and Discussion
Isolation and identification of Lactobacillus species
Out of 470 LAB isolated and tested, 102 isolates were able to resist low pH (i.e. pH 3.00) and
0.4% bile salts which belonged to Enterococcus, Pediococcus and Lactobacillus genus. Among
these isolates88 (18.7%) were identified as Lactobacillus species. Results indicated that the
majority of our isolates did not survive transiently through the GI tract. Obviously, other bacte-
ria such as viable but nonculturable (VBNC), which might have been present in our samples,
were not picked-up for the experimental analysis. Additionally, anaerobic condition, used in
this study for the screening tests, might have corresponded to the close colonic milieu for the
isolation of Lactobacillus. On the other hand, MRS with pH of around 5.5 was used as the cul-
ture medium for the determination of certain biological activities such as vitamin B12 produc-
tion by Lactobacillus. This medium, therefore, may not be an actual representative of the pH
that exists in the colon.
The 88 strains were then identified by multiplex PCR and sequencing to 9 species (Fig 1).Of
the total isolates, a significant numbers of lactobacilli did not show any probiotic properties
and eventually were excluded from the study. Upon the final selection, the isolates which
showed significant properties in biological tests were independent from the age of the donors
and no correlation could be described (p = 0.018), suggesting lack of age-probiotic associated
relationship.
The Lactobacillus isolates were phenotyped using Phene Plate system (PhP-LB) (Fig 2) and
genotyped by Random Amplified Polymorphic DNA (RAPD-PCR) (Fig 3). PhP-LB results
showed the presence of 8 common types (CTs) and 67 single types (STs). RAPD-PCR resulted
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in 6 CTs with 13 isolates (14.8%) and 75 (85.2%) STs. The diversity of the isolates using Simp-
son’s index showed a high diversity among the isolates with both methods i.e. PhP-LB, Di of
0.994 and RAPD-PCR Di of 0.997. Combination of the two techniques resulted in Di = 0.999
with 84 STs. The results from PhP-LB indicated that the combination of the two techniques
could result in a significant discriminatory power than each of the techniques used alone. In
addition, the results showed that the Lactobacillus species isolated from Iranian population is
highly heterogeneous with no specific disseminated clones.
Vitamin B12 production
Six out of the 88 isolates (7%) i.e. L. plantarum (2), L. rhamnosus (1) and L. brevis (3) were
identified as vitamin B12 producers (Fig 4). Significant vitamin B12 production (>2000 pg/ml)
was observed in one L. plantarum and one L. brevis strains. These 6 strains were isolated from
4 individuals.
Endogenous lactobacilli are important vitamin supplier in humans. World Health Organi-
zation (WHO) has recommended that a level of<150 pmol/L (<203 pg/mL) is considered as
vitamin B12 deficiency [22]. Although lactobacilli flora isolated from volunteer population do
not represent the entire flora of the Iranian populations, it does coincide with a multicenter
study where 29% of the Iranian population were found to be vitamin B12 deficient as compared
to the populations from 8 other countries [23].
Fig 1. Determination of Lactobacillus species that have resistant to acid (pH 3) and bile salts.
doi:10.1371/journal.pone.0144467.g001
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Fig 2. Phenotypic clustering of isolated Lactobacillus sp. with PHP-plate assay.
doi:10.1371/journal.pone.0144467.g002
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Fig 3. Genotypic clustering of isolated Lactobacillus sp. with RAPD PCR assay.
doi:10.1371/journal.pone.0144467.g003
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Antibiotic resistance pattern
Antibiotic susceptibility tests showed that all of the strains were sensitive to chloramphenicol,
amoxicillin and penicillin G. Different degrees of resistant to ciprofloxacin (100%), oxacillin
(86.4%), streptomycin (38.6%), tetracycline (36.4%) and erythromycin (8%) were observed.
The antibiotic susceptibility test and minimum inhibitory concentration (MIC) of the isolates
showed that their resistance patterns were within the acceptable range as suggested by the
EFSA guideline for the probiotics [24]. The isolates that had high resistance level to each of the
tested antibiotics and carried one or more plasmids (data not shown) excluded from further
evaluations (S1 Fig).
Attachment to Caco-2 cells
Different level of adhesion to Caco-2 was observed among the isolates. In all, 44 (50%) isolates
were non-adhesive (i.e. with fewer than 40 bacteria attached in 20 microscopic fields), 19
(22%) were adhesive (with 41–100 bacteria) and 25 (28%) were considered strongly adhesive
Fig 4. B12 vitamin production by 6 different Lactobacillus sp. The results are reported as the mean ± SD
of triplicate samples. Arrow indicates standard deviation and means comparison was done with unpaired t-
test. * indicates statistically significant production of vitamin B12 by the isolates in comparison with the
negative control samples (p<0.05). ** indicates highly significant vitamin B12 production in comparison with
other 4 positive isolates (p<0.001).
doi:10.1371/journal.pone.0144467.g004
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(>101 bacteria). There was no specific correlation between adhering to Caco-2 cells among dif-
ferent species of lactobacilli (p = 0.43).
Colonization capacity is an important criterion for probiotic strains [25] which, in turn,
could stimulate immune system [1] and antagonized adhesion of enteropathogens [26]. In this
study, 44 strains (50%) of Lactobacillus were identified as either adhesive or strongly adhesive
as determined by in vitro attachment assay. Three strongest adhesive strains were L. reuteri
100, L. rhamnosus 133 and L. casei 313 with 491, 399 and 395 bacterial cells in 20 different
microscopic fields, respectively. The adhesion index of our strains was significantly higher than
L. rhamnosus GG adhesion index which has been reported by other investigators using similar
protocol as ours by counting attached bacterial cells in 20 randommicroscopic fields [27].
Antibacterial activity
Amongst the isolated strains, 20 Lactobacillus were found to have antibacterial activities against
up to ten different species (Table 1). All examined Lactobacillus isolates inhibited the growth of
EAEC. Amongst different strains of E. coli, less inhibition was observed against ETEC. Some
strains such as L. plantarum 13, L. plantarum156, L. plantarum78, L. plantarum220 and L.
rhamnosus136 inhibited all the tested pathogens. Out of 11 L. plantarum, 55% showed antibac-
terial activities against all the tested bacteria with the exception of S. typhi, a single L. reuteri
118 was also active against all the other tested bacterial species. The results also showed that
any Lactobacillus isolate could inhibit at least 2 entero-pathogenic bacteria.
Overall, the results from antibacterial activity showed that some of our isolates could pro-
duce substances which, in turn, inhibit the growth of gut pathogens. In a recent study, it was
shown that amongst the Iranian the frequency of diarrhea caused by ETEC was significantly
higher than EPEC and EAEC strains which might have been as the result of gut microbiota
imbalance [28].The use of lactobacilli studied here might, therefore, be beneficial for popula-
tions who have diarrheal disease caused by ETEC. The least inhibitory activity by our Lactoba-
cillus isolates was shown against P. aeruginosa. Almost 50% of our bacterial isolates did not
show anti P. aeruginosa activity. It has been suggested by Tharmaraj et al. [29] that in vitro
antibacterial effect of probiotics against P. aeruginosa in an aerobic condition is not a reliable
evaluation setting.
Anti-proliferation effect of Lactobacillus sp. on Caco-2 cells
Grimound et al. [19] have suggested a 20% inhibition of proliferation of Caco-2 cells could be
used as a selection criterion for anti-proliferative effect. Amongst the 20 Lactobacillus strains
tested, 6 strains (i.e. four L. plantarum and two L. brevis) showed decreased proliferation by
more than 20% (Fig 5). The other 14 strains showed either less than 20% or no effect on the
proliferation of Caco-2 cells after 16h of incubation. The most anti-proliferative effect was
observed with L. plantarum365with an inhibition rate of 44.9±4.9%.
No correlation was found between specific species of Lactobacillus strains and anti-prolifer-
ation Caco-2 cell line (p = 0.316). The importance of in vitro anti-proliferation effect of probi-
otic bacteria is still unknown, although there are some hopeful prospects in their use in cancer
prognosis [30] which supported by previous studies that have reported the changes in gut
microbiota in colorectal cancers and adenoma [31,32]. In our study, L. plantarum strains 42,
241, 365 and 467 showed significant antibacterial and anti-proliferative activities. On the other
hand, L. plantarum strains 13, 156 and 78 showed significant antibacterial activity against all of
the bacterial species examined with no anti proliferative activity. The comparative analysis of
anti-proliferative and antibacterial effect by Lactobacillus isolates suggested that different and
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perhaps multiple biological factors might have been produced and/or exerted by these strains
when present in the two different milieus.
Anti-inflammatory effect of selected isolates in in vitro and in vivo models
None of the tested strains induced secretion of IL-8 in HT-29 cells by themselves (Fig 6). The
results showed L. rhamnosus 195, L. plantarum 240 and L. plantarum 156 decreased LPS-
Fig 5. Anti proliferation effect of selected Lactobacillus sp. on Caco-2 cells using XTT. The results are reported as the mean ± SD of triplicate samples.
The level of 20% inhibition of proliferation of Caco-2 was used as a criterion for anti-proliferative effect. Means comparison was done with unpaired t-test.*
indicates significant anti proliferation effect by 6 Lactobacillus sp. (p<0.05). ** indicates highly significant anti proliferation effect (p<0.001).
doi:10.1371/journal.pone.0144467.g005
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induced IL-8 production by>50% (55.1, 54.8 and 50.6%, respectively). No significant differ-
ence in reduction of LPS-induced IL-8 was found amongst the different species of Lactobacillus
(p = 0.0509).
In animal model used we scored disease activity index (DAI) based on weight loss, fecal char-
acter and fecal occult blood [20]. Administration of dextran sulfate sodium (DSS) shortened the
colon length and increased DAI as expected. L. plantarum strains 42 and 156, L. rhamnosus
strain195 and L. brevis strain 165 significantly reduced DAI score in the bacteria treated mice
(Table 2). Administration of other Lactobacillus species had no effect on DAI of mice. The length
of colon of mice in the DSS group was significantly decreased compared with the normal and Lac-
tobacillus administrated groups except for the mice that were exposed to L. plantarum 365 strain.
All Lactobacillus strains could significantly (p<0.01) prevent the shortening of colon (Table 2).
As expected, a high activity of myeloperoxidase (MPO) in the DSS group was observed com-
pared to the control group (P<0.001). The level of MPO activity was insignificant in the nor-
mal and the groups administrated with L. plantarum strains 42 and 156, L. brevis 165 and L.
rhamnosus 195. In DSS and groups that were administrated with L. plantarum strains 240,
241and 365 and L. brevis 205, the MPO activity was highly significant (p<0.01) (Table 2).
Fig 6. Inhibition of secreted IL-8 of selected Lactobacillus isolates. These isolates were selected based
on their significant activities found in Figs 4 and 5. The results are reported as the mean ± SD of triplicate
samples. Mean comparison was done with unpaired t-test. * & ** indicate statistically significant difference
p<0.05 and p<0.001, respectively, for reduction of IL-8 production by lactobacilli isolates in HT-29 cell line
stimulated with LPS.
doi:10.1371/journal.pone.0144467.g006
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In the present study, acute colitis was induced in Balb/c mice with oral administration of 2%
DSS and the MPO activity was used to assess the tissue infiltration of neutrophils. Analysis of
the level of MPO activity with DAI and colon length showed that DAI was directly related to
the MPO activity where decreased DAI resulted in decreased MPO activity. Some reports [33,
34] have indicated that the reduced degradation of matrix in the intestinal mucosa could be
related to the reduction in MPO activity. We, however, have found that the normal colon
length alone with intact matrix, as determined in pathological examinations, had no correlation
with MPO production, suggesting that other factor(s) may affect the outcome of MPO activity
which, in turn, improves the disease state in potentially probiotic treated experimental model
of colitis. IL-8 production by LPS-stimulated cells was inhibited by almost all Lactobacillus
strains. The potentially probiotic strains which resulted in a significant reduction of MPO i.e.
L. plantarum 42, L. plantarum 156, L. brevis 165 and L. rhamnosus 195 also showed significant
(P<0.01) reduction in IL-8 induction as compared with DSS-induced group. In addition,
MPO activity was unchanged when other Lactobacillus strains were administrated; suggesting
that MPO activity in DSS-induced mice was not correlated with the IL-8 induction. Further-
more, the length of colon was reversed to its normal size, with exception of L. plantarum365,
following potentially probiotic treatment of all DSS-induced animals. Our results also showed
that only four of the selected strains i.e. L. plantarum strains 42 and 156,L. brevis 165 and L.
rhamnosus 195 could significantly reduce the IBD features including MPO activity, DAI and
colon length as compared with DSS group.
Conclusion
To our knowledge this is the first report on the isolation of LAB with probiotic characteristics
from fecal samples of healthy human populations from different regions in Iran. The results
suggest that some of the Lactobacillus strains isolated in this study may be a good replacement
for those lacking vitamin B12 producing lactobacilli. We also showed that the LAB strains in
this population were highly heterogeneous as determined by phenotypic and genotypic tests.
After further evaluation in in vivo models and human clinical trials for determination of bene-
ficial effects of our isolates in natural condition, incorporation of these potentially probiotic
isolates in food is highly advantageous for Iranian populations.
Table 2. Effect of selected Lactobacillus sp. onmyeloperoxidase (MPO) activity, disease activity
index (DAI) and colon length, on DSS-induced colitis. Mean comparison was done with unpaired t-test.
**Highly significantly different from DSS group at P <0.01. *Significantly different from DSS group at
P < 0.05.
Mice group MPO activity (mU/mg) DAI Colon Length
Control 0.115±0.025** 0.1±0.01** 9.6±1.1**
DSS 0.236±0.023 1.7±0.4 7.1±1.1
L. plantarum 42 0.148±0.018** 0.1±0.2** 9.4±1.2**
L. plantarum 156 0.151±0.021* 0.3±0.5** 9.6±0.4**
L. brevis 165 0.123±0.032** 0.1±0.3** 10.2±0.6**
L. rhamnosus 195 0.142±0.028** 0.9±0.8* 10.3±0.3**
L. brevis 205 0.201±0.037 1.5±0.9 8.9±0.9**
L. plantarum 240 0.192±0.041 2.1±0.6 8.5±0.7*
L. plantarum 241 0.230±0.014 1.7±0.2 9.2±0.6**
L. plantarum 365 0.218±0.015 1.5±0.4 8.0±1.3
L. plantarum 467 0.161±0.027* 1.1±0.3 11.1±0.4**
L. brevis 470 0.169±0.031* 1.1±0.2 9.7±1.0**
doi:10.1371/journal.pone.0144467.t002
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